We are live on ! Find out more
EFM

E Fund Management Portfolio holdings

AUM $4.46B
This Fund
S&P 500
This Quarter Est. Return
-2.75%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$1.99B
AUM Growth
+$45.8M
Cap. Flow
+$213M
Cap. Flow %
10.7%
Top 10 Hldgs %
56.29%
Holding
416
New
63
Increased
249
Reduced
78
Closed
21

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$39.6M
2
NVDA icon
NVIDIA
NVDA
+$38M
3
MSFT icon
Microsoft
MSFT
+$36.6M
4
AMZN icon
Amazon
AMZN
+$12.2M
5
YUMC icon
Yum China
YUMC
+$10.6M

Top Sells

Rank Stock Value
1
PDD icon
Pinduoduo
PDD
+$45M
2
FUTU icon
Futu Holdings
FUTU
+$16.1M
3
TSM icon
TSMC
TSM
+$13.2M
4
AMAT icon
Applied Materials
AMAT
+$7.81M
5
TME icon
Tencent Music
TME
+$4.18M

Sector Composition

Rank Sector Weight
1 Technology 40.04%
2 Consumer Discretionary 27.82%
3 Communication Services 8.98%
4 Healthcare 6.75%
5 Financials 5.07%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EQIX icon
351
Equinix
EQIX
$103B
$221K 0.01%
234
-54
-19% -$49.7K
MO icon
352
Altria Group
MO
$115B
$219K 0.01%
+4,195
New +$223K
TVTX icon
353
Travere Therapeutics
TVTX
$6.19B
$217K 0.01%
+12,481
New +$221K
IDYA icon
354
IDEAYA Biosciences
IDYA
$3.87B
$215K 0.01%
8,364
+267
+3% +$7.56K
ICE icon
355
Intercontinental Exchange
ICE
$91.1B
$214K 0.01%
+1,439
New +$228K
SLNO
356
DELISTED
Soleno Therapeutics
SLNO
$211K 0.01%
+4,703
New +$244K
NTLA icon
357
Intellia Therapeutics
NTLA
$1.8B
$210K 0.01%
18,053
+1,634
+10% +$25.5K
ARQT icon
358
Arcutis Biotherapeutics
ARQT
$2.99B
$207K 0.01%
14,879
-2,906
-16% -$31.8K
CME icon
359
CME Group
CME
$103B
$207K 0.01%
+892
New +$205K
TT icon
360
Trane Technologies
TT
$98.8B
$206K 0.01%
557
-784
-58% -$311K
MDB icon
361
MongoDB
MDB
$35.9B
$204K 0.01%
+878
New +$248K
IMVT icon
362
Immunovant
IMVT
$8.51B
$204K 0.01%
8,250
-1,539
-16% -$43.7K
DNLI icon
363
Denali Therapeutics
DNLI
$3.84B
$204K 0.01%
9,997
+2,436
+32% +$62.4K
NVAX icon
364
Novavax
NVAX
$1.53B
$204K 0.01%
25,340
+1,219
+5% +$11.8K
PH icon
365
Parker-Hannifin
PH
$125B
$204K 0.01%
+320
New +$212K
DUK icon
366
Duke Energy
DUK
$93.8B
$202K 0.01%
+1,873
New +$212K
ENPH icon
367
Enphase Energy
ENPH
$4.92B
$201K 0.01%
2,925
+976
+50% +$77.4K
ACAD icon
368
Acadia Pharmaceuticals
ACAD
$5.02B
$195K 0.01%
10,628
-7,704
-42% -$124K
ARDX icon
369
Ardelyx
ARDX
$984M
$192K 0.01%
37,827
-366
-1% -$2.02K
MOMO
370
Hello Group
MOMO
$845M
$190K 0.01%
24,678
-17,682
-42% -$126K
SNDX icon
371
Syndax Pharmaceuticals
SNDX
$1.74B
$167K 0.01%
12,603
+1,583
+14% +$27.1K
MYGN icon
372
Myriad Genetics
MYGN
$302M
$161K 0.01%
+11,752
New +$217K
DAWN
373
DELISTED
Day One Biopharmaceuticals
DAWN
$143K 0.01%
+11,276
New +$157K
MNKD icon
374
MannKind Corp
MNKD
$1.27B
$142K 0.01%
22,039
+1,828
+9% +$12.3K
RCKT icon
375
Rocket Pharmaceuticals
RCKT
$424M
$139K 0.01%
+11,054
New +$166K

Similar funds

E Fund Management's Q4 2024 Portfolio in Review

As of Q4 2024, E Fund Management held 416 positions worth $1.99B, up 2.4% from $1.95B the previous quarter. Its ten largest holdings account for 56% of the portfolio.

E Fund Management deployed $213M of net new capital in Q4 2024, opening 63 new positions and adding to 249 existing holdings. Its largest new stake was Yum China: 222,743 shares worth $10.7M.

By sector, the portfolio is most concentrated in Technology at 40% of assets, up from 31% a quarter earlier, followed by Consumer Discretionary and Communication Services.

On the sell side, the largest reduction was Pinduoduo, an estimated $45M trimmed.

  • E Fund Management's largest Q4 2024 buy was Yum China: 222,743 shares worth $10.7M.
  • E Fund Management added most to Apple in Q4 2024, an estimated $39.6M increase.
  • E Fund Management's biggest Q4 2024 reduction was Pinduoduo, cutting an estimated $45M.
  • E Fund Management fully exited Lufax Holding in Q4 2024, selling an estimated $3.9M.
  • E Fund Management's ten largest holdings make up 56% of its $1.99B portfolio in Q4 2024.
  • E Fund Management opened 63 new positions and closed 21 in Q4 2024.
  • E Fund Management's portfolio value rose 2.4% quarter-over-quarter to $1.99B.

Based on E Fund Management's 13F filing for Q4 2024, filed 7 Feb 2025.